Nilsson P M, Nilsson J-A, Hedblad B, Berglund G, Lindgärde F
Department of Internal Medicine, University Hospital, Malmö, Sweden.
J Intern Med. 2002 Jul;252(1):70-8. doi: 10.1046/j.1365-2796.2002.01010.x.
To study effects on non-cancer mortality of observational weight loss in middle-aged men stratified for body mass index (BMI), taking a wide range of possible confounders into account.
Prospective, population based study.
Male population of Malmö, Sweden.
In all 5722 men were screened twice with a mean time interval of 6 years in Malmö, southern Sweden. They were classified according to BMI category at baseline (<21, 22-25, overweight: 26-30, and obesity: 30+ kg m(-2)) and weight change category until second screening (weight stable men defined as having a baseline BMI +/- 0.1 kg m(-2) year-1 at follow-up re-screening).
Non-cancer mortality calculated from national registers during 16 years of follow-up after the second screening. Data from the first year of follow-up were excluded to avoid bias by mortality caused by subclinical disease at re-screening.
The relative risk (RR; 95% CI) for non-cancer mortality during follow-up was higher in men with decreasing BMI in all subgroups: RR 2.64 (1.46-4.71, baseline BMI <21 kg m(-2)), 1.39 (0.98-1.95, baseline BMI 22-25 kg m(-2)), and 1.71 (1.18-2.47, baseline BMI 26+ kg m(-2)), using BMI-stable men as reference group. Correspondingly, the non-cancer mortality was also higher in men with increasing BMI, but only in the obese group (baseline BMI 26+ kg m(-2)) with RR 1.86 (1.31-2.65). In a subanalysis, nonsmoking obese (30+ kg m(-2)) men with decreased BMI had an increased non-cancer mortality compared with BMI-stable obese men (Fischer's test: P=0.001). The mortality risk for nonsmoking overweight men who increased their BMI compared with BMI-stable men was also significant (P=0.006), but not in corresponding obese men (P=0.094). CONCLUSIONS. Weight loss in self-reported healthy but overweight middle-aged men, without serious disease, is associated with an increased non-cancer mortality, which seems even more pronounced in obese, nonsmoking men, as compared with corresponding but weight-stable men. The explanation for these observational findings is still enigmatic but could hypothetically be because of premature ageing effects causing so-called weight loss of involution.
研究体重指数(BMI)分层的中年男性观察性体重减轻对非癌症死亡率的影响,并考虑一系列可能的混杂因素。
前瞻性、基于人群的研究。
瑞典马尔默的男性人群。
在瑞典南部的马尔默,共有5722名男性接受了两次筛查,平均时间间隔为6年。根据基线时的BMI类别(<21、22 - 25、超重:26 - 30以及肥胖:30 + kg/m²)和第二次筛查前的体重变化类别对他们进行分类(体重稳定的男性定义为在随访重新筛查时基线BMI ± 0.1 kg/m²/年)。
第二次筛查后16年随访期间根据国家登记数据计算的非癌症死亡率。排除随访第一年的数据以避免因重新筛查时亚临床疾病导致的死亡率偏差。
在所有亚组中,BMI下降的男性随访期间非癌症死亡率的相对风险(RR;95%CI)更高:以BMI稳定的男性为参照组,RR为2.64(1.46 - 4.71,基线BMI <21 kg/m²)、1.39(0.98 - 1.95,基线BMI 22 - 25 kg/m²)以及1.71(1.18 - 2.47,基线BMI 26 + kg/m²)。相应地,BMI上升的男性非癌症死亡率也更高,但仅在肥胖组(基线BMI 26 + kg/m²),RR为1.86(1.31 - 2.65)。在一项亚分析中,BMI下降的非吸烟肥胖(30 + kg/m²)男性与BMI稳定的肥胖男性相比,非癌症死亡率增加(费舍尔检验:P = 0.001)。与BMI稳定的男性相比,BMI上升的非吸烟超重男性的死亡风险也具有显著性(P = 0.006),但相应肥胖男性中无显著性差异(P = 0.094)。结论。自我报告健康但超重的中年男性在无严重疾病情况下体重减轻与非癌症死亡率增加相关,与相应体重稳定的男性相比,这在肥胖、非吸烟男性中似乎更为明显。这些观察结果的解释仍然不明,但推测可能是由于过早衰老效应导致所谓的 involution性体重减轻。